Luiz Cesar Cavalcanti Pereira da Silva

Dr. Luiz Cesar Cavalcanti Pereira da Silva

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 April 2025 in Veterinary Sciences
Verified
Journal Article
Open access
PDF file
RNRemco Alexander Nederlof
Remco Alexander Nederlof
TVTommaso Virgilio
Tommaso Virgilio
HSHendrickus J. J. Stemkens
Hendrickus J. J. Stemkens
LSLuiz Cesar Cavalcanti Pereira da Silva
Luiz Cesar Cavalcanti Pereira da Silva
DMDaniela Montagna
Daniela Montagna
Jaco BakkerJaco Bakker
Jaco Bakker
Yellow fever (YF) causes severe morbidity and mortality in Africa and South America. It is an arthropod-borne viral disease endemic to tropical regions of Africa and South America. Yellow fever virus (YFV) is transmitted by mosquitoes and frequently affects both non-human primates (NHPs) and humans. Neotropical primates (NTPs) are generally more severely afflicted by YFV than African primates. Asian primates appear not to be susceptible to this disease. Susceptibility varies among NTP species: asymptomatic infections are described in some NTP species, whereas severe epizootic mortality events are described in others. The genus Alouatta (howler monkeys) is considered to be the most susceptible among the NTPs. Epizootic events resulting in the death of thousands of NTPs have been recorded in recent history. As a result, YFV poses a threat to the survival of some NTP species. In most cases, NTPs are found dead without showing prior clinical signs. In cases where clinical signs are observed, they are mostly non-specific. Due to their high susceptibility, epizootic events in NTPs are used as epidemiological predictors for human YF outbreaks. YFV infection may be diagnosed by means of virus isolation, reverse transcription polymerase chain reaction, serology, histopathology, or immunohistochemistry. Animals that survive the disease develop neutralizing antibodies to YFV. Currently, no specific treatment is available. Sustained YF control strategies must rely on surveillance and accurate diagnostics to allow for early detection of outbreaks and rapid implementation of control measures. Prophylaxis should be based on a One Health perspective that recognizes the intricate interplay between human health, primate health, and the environment. Vaccines for YF are available, with the human 17DD vaccine effectively preventing disease in primates. However, mitigation strategies continue to rely more and more on vector control, preferably using eco-friendly methods. Climate change and human activities, and their impact on local ecology, are assumed to increase the risk of YF transmission in the next decades.

29 April 2024 in Animals
Verified
Journal Article
Open access
PDF file
Igor Falco ArrudaIgor Falco Arruda
Igor Falco Arruda
MAMaria Regina Reis Amendoeira
Maria Regina Reis Amendoeira
TBThamires Francisco Bonifácio
Thamires Francisco Bonifácio
CRClarissa Nascimento da Silveira Raso
Clarissa Nascimento da Silveira Raso
HEHyago da Silva Medeiros Elidio
Hyago da Silva Medeiros Elidio
ISIsabele Barbieri dos Santos
Isabele Barbieri dos Santos
The highly virulent Toxoplasma gondii RH strain is maintained through successive passages in mice, but there is still a lack of studies that refine these procedures from a 3Rs perspective, where humanitarian ideals aim to minimize the stress, pain, or suffering of the animals used in the research without the loss of results. The aim of this study was to establish humane endpoints in Swiss Webster mice inoculated with the T. gondii RH strain. A total of 52 mice were infected with 5 × 106 tachyzoites/mL and monitored for periods of up to 5 days. The parameters body weight; hair condition; higher than normal body temperature; hypothermia; respiratory function; pain; soft stools or diarrhea; bloody diarrhea; tense, nervous, or in distress during handling; and ascites were recorded daily in score tables. The results showed that prominent piloerection, respiratory function, pain parameters, and ascites are important clinical signs to be used as a cut-off point for implementing euthanasia. The application of this refinement method helped to avoid animal suffering and pain without compromising the number of parasites recovered. We therefore suggest adopting these parameters in research protocols that require the maintenance of the T. gondii RH strain in murine models to avoid and reduce animal suffering.

25 November 2025 in Journal of Medical Primatology
Verified
Journal Article
Open access
AMAnnemiek Maaskant
Annemiek Maaskant
MMMargot Morel
Margot Morel
SJSherrie Jean
Sherrie Jean
BKBon-Sang Koo
Bon-Sang Koo
SNSiavash Noor
Siavash Noor
Jaco BakkerJaco Bakker
Jaco Bakker
Leptospirosis is an emerging zoonotic disease caused by pathogenic Leptospira spp., affecting a wide range of domestic and wild mammals including nonhuman primates ( NHPs ). Despite rising incidence rates in both NHPs and humans, there is a lack of comprehensive resources addressing leptospirosis in NHPs from a veterinary perspective in a One Health approach. The close phylogenetic relationship between NHPs , humans and the similarities in disease progression may reveal valuable insights into the pathophysiology, diagnosis, treatment, control measures, and surveillance of leptospirosis. This review synthesizes existing literature on leptospirosis in NHPs , focusing on diagnosis, control measures, and surveillance. It offers insights into the prevalence among NHPs , environmental and civilization factors affecting Leptospira spp. dynamics, and recommendations for the diagnosis, management, and monitoring of leptospirosis. The findings highlight the need for coordinated research efforts and integrated surveillance systems to reduce leptospirosis risk in NHPs .

29 May 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
DMDaniela V. Müller
Daniela V. Müller
MGMatheus Gallas-Lopes
Matheus Gallas-Lopes
MAMariana B. Abreu
Mariana B. Abreu
BABruno Arbo
Bruno Arbo
LBLeonardo M. Bastos
Leonardo M. Bastos
AHAna P. Herrmann
Ana P. Herrmann
Social behavior is a fundamental phenotype across vertebrates. Zebrafish ( Danio rerio ) have emerged as a valuable translational model for investigating the neurobiological mechanisms underlying sociability, particularly due to their robust shoaling behavior and experimental tractability. However, the literature presents issues of reproducibility and inconsistent findings regarding the modulation of social preference and shoal cohesion in adult zebrafish. We conducted a systematic review and meta-analysis to synthesize studies evaluating the effects of pharmacological interventions that modulate the central nervous system and stress-related interventions on social behavior in adult zebrafish and, when available, anxiety-like behavior. The literature search was performed in three databases (Embase, PubMed, and Web of Science), followed by a two-step screening process based on inclusion/exclusion criteria. The included studies underwent extraction of qualitative and quantitative data, as well as risk of bias assessment. Interventions from the included studies (n = 108) were categorized according to their nature, mechanism of action, and/or therapeutic purpose, resulting in seven, four, and five meta-analyses for social preference, shoal cohesion, and anxiety-related tests, respectively. Ethanol, NMDA antagonists, pro-dopaminergic agents, and stress-related interventions decreased social preference, while stress-related interventions increased shoal cohesion. The fact that stress produced opposite effects suggests that these paradigms measure distinct sociability constructs, or perhaps are differentially modulated by confounding factors, like anxiety for example. The studies presented high heterogeneity, with prediction intervals compatible with effects in both directions, as well as methodological limitations and deficiencies in data reporting, as evidenced by the risk of bias assessment. These findings emphasize the need for well-designed new studies to validate the findings and expand the evidence on interventions that currently lack sufficient studies for quantitative synthesis.

22 November 2024 in Laboratories
Verified
Journal Article
Open access
PDF file
JLJulie Leleu
Julie Leleu
MSMaxime SIMON
Maxime SIMON
LSLuiz Cesar Cavalcanti Pereira da Silva
Luiz Cesar Cavalcanti Pereira da Silva
TVTommaso Virgilio
Tommaso Virgilio
MGMelissa Ann de la Garza
Melissa Ann de la Garza
Jaco BakkerJaco Bakker
Jaco Bakker
Rectal prolapse is a common condition in laboratory-housed macaques, usually associated with recurrent gastroenteritis and stress. However, evidence for both statements is lacking. Therefore, the prevalence of rectal prolapses and their risk factors in laboratory-housed macaques have yet to be assessed. In addition, a standard of care pharmacological treatment remains to be recognized and documented. Thus, a retrospective study involving 816 laboratory-housed macaques was conducted, in which the prevalence, risk factors, and treatment success of rectal prolapses was assessed. The prevalence was shown to be 3.92%, and all cases could be either directly or indirectly linked to stress factors. By eliminating the suggested stressor, most rectal prolapses reverted naturally (69%). Moreover, we discuss the advantage of the ancillary administration of hyoscine butylbromide and metamizole as a treatment modality.